Clinical studies of topiramate

Drugs of Today

Volumn 35, Issue 1, 1999, Pages 49-57

  Faught, Edward ^a,b  

^a UNIVERSITY OF ALABAMA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TOPIRAMATE;

ANOREXIA; ATAXIA; BEHAVIOR DISORDER; COGNITIVE DEFECT; DEPRESSION; DRUG CLEARANCE; DRUG EFFICACY; FOCAL EPILEPSY; GENERALIZED EPILEPSY; GRAND MAL EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; NEPHROLITHIASIS; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; TERATOGENESIS; VERTIGO; WEIGHT REDUCTION;

EID: 0033017039     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.1999.35.1.522948     Document Type: Review

References (23)

1. Mattson, R.H., Cramer, J.A., Collins, J.F. et al. Comparison of carbamazepine, phenobarbital, phenytoin, and primidone in partial and secondarily generalized tonic-clonic seizures. New Engl J Med 1985, 313: 145-51.
2. Mattson, R.H., Cramer, J.A., Collins, JF. A comparison of valproate with carbamazepine for the treatment of complex partial seizures and secondarily generalized tonic-clonic seizures in adults. The Department of Veterans Affairs Epilepsy Cooperative Study No. 264 Group. New Engl J Med 1992, 327: 765-71.
3. Faught, E., Wilder, B.J., Ramsay, R.E. et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200, 400, and 600 mg daily dosages. Neurology 1996, 6: 1684-90.
4. Privitera, M., Fincham, R., Penry, J. et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600, 800, 1000 mg daily dosages. Neurology 1996, 6: 1678-83.
5. Sharief, M., Viteri, C., Ben-Menachem, E. et al. Double-blind, placebo-controlled study of topiramate in patients with refractory partial epilepsy. Epilepsy Res 1996, 25: 217-24.
6. Tassinari, C., Chauvel, P., Chodkiewicz, J. et al. Double-blind placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Epilepsia 1996, 37: 763-8.
7. Ben-Menachem, E., Henriksen, O., Dam, M. et al. Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia 1996, 36: 539-43.
8. Topamax package insert. Ortho-McNeil Pharmaceuticals, 1997.
9. Sachdeo, S.K., Sachdeo, R.C., Reife, R.A. et al. Topiramate: Double-blind trial as monotherapy. Epilepsia 1997, 38: 294-8.
10. Eltermann, R., Glauser, T.A., Ritter, R.J. Topiramate as adjunctive therapy in pediatric patients with partial-onset seizures. Epilepsia 1997, 38 (Suppl. 8): 98.
11. Elterman, R., Glauser, T., Ritter, F.J. et al. Efficacy and safety of topiramate in partial seizures in children. Neurology 1997, 48: 1729.
12. Glauser, T.A., Sachdeo, R., Ritter, F.J. et al. Topiramate as adjunctive therapy in Lennox-Gastaut syndrome. Epilepsia 1997, 38 (Suppl. 8): 207.
13. Reife, R., Pledger, G., Lim, P., Karim, R. Topiramate: Pooled analysis of six placebo-controlled trials. Epilepsia 1996, 37 (Suppl. 4): 74.
14. Biton, V., Montouris, G.D., Riviello, J.D. et al. Efficacy and safety of topiramate in generalized tonic-clonic seizures of nonlocal origin. Epilepsia 1997, 38 (Suppl. 8): 206-7.
15. Faught, E., French, J., Harden, C. et al. Adverse effects of topiramate: Results from a large post-marketing survey. Epilepsia 1997, 38 (Suppl. 8): 97.
16. Ramsay, R.E., DeToledo, J., DeToledo, E. Tonic-clonic seizures: A systematic review of antiepilepsy drug efficacy and safety. Clin Ther 1997, 19: 433-46.
17. Faught, E., Kuzniecky, R.I., Gilliam, F. Cognitive adverse effects of topiramate. Neurology 1997, 48 (3): A336.
18. Khan, A., Faught, E., Kuzniecky, R. et al. Acute psychotic symptoms induced by topiramate. Epilepsia 1997, 38 (Suppl. 8): 97.
19. Rosenfeld, W.E., Kanner, A.,. Jacobson, M. Topiramate and concomitant weight loss. Epilepsia 1997, 38 (Suppl. 8): 98.
20. Wasserstein, A.G., Rak, I., Reife, R.A. Nephrolithiasis during treatment with topiramate. Epilepsia 1995, 36 (Suppl. 3): S153.
21. Unpublished data on file at RW Johnson Pharmaceutical Research Institute.
22. Glauser, T.A. Topiramate. Semin Ped Neurol 1997,4(1): 34-42.
23. Pledger, G., Reife, R., Lim, P., Karim, R. Overview of topiramate efficacy from adjunctive therapy trials. Epilepsia 1995, 36 (Suppl. 3): S150.